You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Merck
Mallinckrodt
Express Scripts

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

HYDROXYCHLOROQUINE SULFATE Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Which patents cover Hydroxychloroquine Sulfate, and when can generic versions of Hydroxychloroquine Sulfate launch?

Hydroxychloroquine Sulfate is a drug marketed by Alkaloida Zrt, Amneal Pharms Co, Hikma Pharms, Invatech, Ipca Labs Ltd, Laurus Labs Ltd, Lupin Ltd, Mylan, Sandoz, Teva Pharms, Twi Pharms, Watson Labs, and Zydus Pharms Usa Inc. and is included in thirteen NDAs.

The generic ingredient in HYDROXYCHLOROQUINE SULFATE is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Hydroxychloroquine Sulfate

A generic version of HYDROXYCHLOROQUINE SULFATE was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.

  Start Trial

Drug patent expirations by year for HYDROXYCHLOROQUINE SULFATE
Drug Sales Revenue Trends for HYDROXYCHLOROQUINE SULFATE

See drug sales revenues for HYDROXYCHLOROQUINE SULFATE

Recent Clinical Trials for HYDROXYCHLOROQUINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
First Affiliated Hospital of Harbin Medical UniversityPhase 4
Children's Hospital of Fudan UniversityN/A
Peking University First HospitalPhase 2

See all HYDROXYCHLOROQUINE SULFATE clinical trials

Pharmacology for HYDROXYCHLOROQUINE SULFATE
Medical Subject Heading (MeSH) Categories for HYDROXYCHLOROQUINE SULFATE
Synonyms for HYDROXYCHLOROQUINE SULFATE
(+-)-2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt)
118-42-3 (Parent)
2-((4-((7-Chloro-4-quinolinyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt)
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt)
2-((4-((7-Chloroquinolin-4-yl)amino)-pentyl)(ethyl)amino)ethanol sulfate
2-((4-((7-chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethan-1-ol sulfate
2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol sulfate
2-((4-(7-chloroquinolin-4-ylamino)pentyl)(ethyl)amino)ethanol sulfate
2-({4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino)ethan-1-ol; sulfuric acid
2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol sulfate
2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol; sulfuric acid
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol; sulfuric acid
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid
4CH-007360
7-Chloro-4-[4-[ethyl-(2-hydroxyethyl)amino]-1-methylbutylamino]quinoline
7-Chloro-4-[4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-methylbutylamino]quinoline Sulfate
747-36-4
747H364
AB0015282
AC1L20PB
ACM1216432562
AI3-52706
AK-72909
AKOS015897337
AN-22118
ANW-43969
API0025948
AX8134190
BCP12823
BR-72909
C18H26ClN3O.H2O4S
C18H28ClN3O5S
CAS-747-36-4
CCG-39154
CHEMBL1690
CPD000525253
CS-8017
CTK8B4131
D02114
DSSTox_CID_27788
DSSTox_GSID_47811
DSSTox_RID_82563
DTXSID1047811
EINECS 212-019-3
Ercoquin
Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethyl)amino-, (+-)-, sulfate (1:1) salt
Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-, sulfate (1:1)
Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt)
Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt)
Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt) (8CI)
Ethanol, monosulfate
Ethanol, sulfate (1:1) (salt)
FT-0603511
HCQ sulfate
HMS1922O12
HMS2093O05
HMS3713J22
HY-B1370
HYDROXYCHLOROQINE SULFATE
Hydroxychloroquine Sulfate ,(S)
Hydroxychloroquine sulfate (JAN/USP)
Hydroxychloroquine sulfate [USP]
Hydroxychloroquine sulfate, >=98% (HPLC), powder
Hydroxychloroquine sulfate, 98%
Hydroxychloroquine Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
Hydroxychloroquine sulfate, United States Pharmacopeia (USP) Reference Standard
Hydroxychloroquine sulphate
Hydroxychloroquine Sulphate 1.0 mg/ml in Methanol (as free base)
hydroxychloroquine; sulfuric acid
Hydroxycloroquine sulfate, analytical standard
J10260
KB-219927
KS-00000GEU
KS-5311
LS-66615
M567
MCULE-4122662001
MolPort-003-666-519
N4-(7-Chloro-4-quinolyl)-N1-ethyl-N1-(2-hydroxyethyl)-1,4-pentanediamine Sulfate
NCGC00095090-01
NCGC00095090-02
NCGC00159483-02
NCGC00159483-04
NSC 4375
NSC-4375
NSC-758663
NSC758663
Oxichlorochine Sulfate
Pharmakon1600-01503978
Plaquenil (TN)
Plaquenil sulfate
Plaquinol
PubChem15393
S-2011
s4430
SAM001246735
SB19140
SCHEMBL41114
SPECTRUM1503978
SR-05000001881
SR-05000001881-1
SR-05000001881-2
ST24030764
TCMDC-123987
Toremonil
Tox21_111707
Tox21_111707_1
TR-024132
W-104413
Z1551900864

US Patents and Regulatory Information for HYDROXYCHLOROQUINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkaloida Zrt HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 201691-001 May 8, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 210543-001 Jul 6, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
Invatech HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040150-001 Jan 27, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040133-001 Nov 30, 1995 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Johnson and Johnson
McKinsey
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.